bioportfolio.com

bioportfolio.com
Share

bioportfolio.com

 •  September 26

Porvair Sciences offers a range of application optimised microplates and high-performance microplate equipment designed to enable drug discovery scientists to optimise sample preparation and improve productivity. For laboratories looking to remove the traditional drug discovery 'bottleneck' of solvent evaporation the Mistral nitrogen blowdown...

bioportfolio.com

 •  September 19

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a...

bioportfolio.com

 •  September 16

Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74... In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their...

bioportfolio.com

 •  August 23

Life Sciences Jobs ... SimpleTrials, the latest Clinical Trial Management System (CTMS) from Trial By Fire Solutions, has been recognized as one of the Top 10 eClinical Trial Management Solution Providers for 2017 by Pharma... Trial By Fire Solutions is pleased to announce that SimpleTrials has been selected by the Drug Information Association...

bioportfolio.com

 •  August 8

Myoderm, a global clinical trial drug supply specialist, today announced the addition of Andy Shepard to its business development team. NORRISTOWN, PA (PRWEB) August 08, 2017 Myoderm, a global clinical trial drug supply specialist, today announced the addition of Andy Shepard to its business development team. This announcement comes on the heels of...

bioportfolio.com

 •  June 16

Social media aggregation site will highlight real-time digital conversations at DIA 2017 ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that for the second consecutive year it will present DIA Live – a social media aggregation...

bioportfolio.com

 •  May 22

Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women's health pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for female infertility, polycystic ovarian syndrome and...

bioportfolio.com

 •  May 20

Choosing the right commercial model for orphan drug success The societal and commercial ambitions of orphan drug developers determine which commercial model will best meet their aims. Profit, potential and patient benefit all play a part, so which model is best and what are the considerations which underpin that choice? This report analyses current...

bioportfolio.com

 •  April 29

Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ... Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and...

bioportfolio.com

 •  April 23

After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid-April, the authority had approved more new drugs than during the same quarter of during the past six years. Original Article: FDA Drug Approvals up Sharply in Q1 NEXT...